Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Fragile Histidine Triad
100%
Poor Prognostic Marker
100%
Primary Breast Tumor
33%
Cyclooxygenase-2
22%
Metastatic Axillary Lymph Node
22%
Primary Tumor
16%
Inverse Correlation
11%
P53 Expression
11%
Cyclooxygenase-2 Expression
11%
Bcl-2 Expression
11%
Lymph Node Positive
11%
Breast Tumor Tissues
11%
Apoptosis
5%
Immunohistochemistry
5%
Oncogenesis
5%
Predictive Value
5%
Ki-67
5%
Tumor Suppressor Gene
5%
B-cell Lymphoma 2 (Bcl-2)
5%
Tumor Specimens
5%
Tumor Size
5%
Tissue Expression
5%
Poor Prognostic
5%
Prognostic Value
5%
Clinical Markers
5%
Tumor Grade
5%
Metastatic Lymph Node
5%
Long Follow-up
5%
Prognostic Features
5%
Histological Markers
5%
High Proliferation Index
5%
Large-scale Trials
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Histidine
100%
Cyclooxygenase 2
33%
Breast Tumor
33%
Protein P53
22%
Primary Tumor
16%
Carcinogenesis
5%
Neoplasm
5%
Tumor Suppressor Protein
5%
Lymph Node Metastasis
5%
Neuroscience
Histidine
100%
Lymph Node
38%
Cyclooxygenase 2
33%
P53
22%
Bcl-2
16%
Immunohistochemistry
5%
Tumor Suppressor Gene
5%
Carcinogenesis
5%
Programmed Cell Death
5%
Immunology and Microbiology
Histidine
100%
Cyclooxygenase
33%
P53
22%
Axillary Lymph Node
22%
Lymph Node
16%
Bcl-2
16%
Tumor Volume
5%
Tumor Suppressor Gene
5%
Programmed Cell Death
5%
Biochemistry, Genetics and Molecular Biology
Histidine
100%
Cyclooxygenase
33%
P53
22%
Bcl-2
16%
Carcinogenesis
5%
Tumor Suppressor Gene
5%
Tumor Volume
5%
Programmed Cell Death
5%
Ki-67
5%